Two Icahn engagements in recent years, two different outcomes…
Three if you count ImClone :- )
The strange thing about the Biogen-Idec merger is that Idec was nominally the acquiring company and yet there is no trace of it left other than the Roche JV.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”